Devicare Raises 3 Million Euros in its Commitment to 'Remote Patient Monitoring'

DevicareDevicare, a company specializing in innovative medical devices for chronic home care patients under Remote Patient Monitoring (RPM), has closed out a seed round of 3 million euros. This funding will be used to consolidate the launch of clinical studies of two of Devicare's main product lines on the Spanish market: Lit-Contro l® for prevention and self-management of recurring urinary diseases and Tao-Contro l® for self-management of patients who take oral anticoagulants (Sintrom®, Aldocumar ®, etc.).

The round opened in 2016 with the entrance of the investment holding company EMESA Corporación Empresarial (a company of Emilio Cuatrecasas). Different Family Offices and corporate partners were later incorporated, such as Juan Knuth (Palex Medical), the Gaya family (Eladiet), the Xiol family (Peroxfarma), the Serra family (Boyser), among others, in addition to employees of the company.

"This profile of investors is without a doubt a large strategic contribution to our company's growth", says the founder and CEO of Devicare, Rosendo Garganta, who also coordinates the commission on medical technology of CataloniaBio. It is a growth which is connected to Remote Patient Monitoring (RPM). In 2016, according to data by the Berg Insight, the global RPM market grew by 44% and it is estimated that the number of patients monitored will reach 50.2 million in the next 4 years, of which 25.2 million will be connected to home medical devices such as the ones made by Devicare.

"We are convinced that this is the way to improve healthcare management and the quality of life for patients who suffer from chronic diseases," explains Xavier Peris, sales and marketing director at Devicare. For example, urologic diseases (lithiasis, infection, overactive bladder, painful bladder syndrome, interstitial cystitis, calcification of urinary catheters...) are already the second cause of primary care visits in Europe.

Devicare's devices enable a chronic patient to more consistently control their condition from their home without losing contact with their doctor. "We are talking about the 4 Ps of medicine: Preventing, Predicting, Personalizing and Participating. Health care centers are becoming decentralized," say both Garganta and Peris. Furthermore, the ENISA Entrepreneurs line of credit of the National Innovation Company (ENISA) recently granted Devicare a loan of 270,000 euros. Since the company was founded, Devicare has raised a total of 4.5 million euros.

For further information, please visit:
http://www.devicare.com/en/

About Devicare
Devicare is a company specialized in the development, manufacture and remote management of innovative medical devices for the home care of chronic patients. These solutions are developed under the concept of Remote Patient Monitoring (RPM) in order to enable the patient to actively participate in the monitoring of their disease with the use of the devices. These products are placed on the market through agreements with pharmaceutical companies.

Devicare’s headquarters is located at the UAB Research Park, in Cerdanyola del Vallès, near Barcelona (Spain). In 2017, the company invoiced €1.1 million. It has a staff of 20 professionals.

About Lit-Control® for recurrent urinary diseases
Devicare has been a pioneer in developing a domiciliary method for the self-management of frequent urological pathologies called Lit-Contro l®. This method is made up by the Lit-Control® pH Meter medical device and the Lit-Control® pH Up and Lit-Control® pH Down food supplements. Lit-Control® enables patients to monitor and control their urine pH in a simple, accurate and reliable way, thereby preventing, treating and/or avoiding the recurrence of a wide range of urological disorders. On the other hand, it offers doctors greater possibilities for monitoring and controlling patients, as well as greater adherence and treatment effectiveness.

Tao-Control® for anticoagulated patients
Tao-control® is the first service that enables patients taking oral anticoagulants (anti-vitamin K such as Sintrom® or Aldocumar®) to self-manage INR levels from their own home (always under their doctor’s supervision). It reduces mortality by up to 63% and associated complications by up to 50%. Currently Tao-Control® is offered to patients at 39 euros a month (including a state-of-the-art coagulometer and all of the necessary materials to be able do self-management on a weekly basis, training, monitoring, and also provides access to records). In Spain alone, there are 800,000 patients who require this type of care.

Most Popular Now

Leading Health Systems Sign On to Delive…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the expanding adoption of its Population Health Management solutions with health systems across the globe, including...

Pflegetiger Adds Digital Health Ventures…

Since summer 2016, Pflegetiger has been developing its innovative concept of neighborhood care, a concept designed to make in-home care attractive for care professionals again. The company's revolutionary approach -...

Can Virtual Reality be Used to Manage Pa…

Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center. Children undergo necessary yet painful and distressing medical procedures...

MSD Innovation Factory is Looking for Di…

MSD is looking for innovators to solve 7 health-related challenges. One of them seeks to support anaesthesiologists with their continuous education (e.g. at the operation room) or their team building...

Integrated Lab-on-a-Chip Uses Smartphone…

A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care...

Free iPhone App could Guide MS Research…

For some diseases, a simple blood test is all that's needed to estimate severity or confirm a diagnosis. Not so for multiple sclerosis. No single lab test can tell doctors...

Giving Rookie Dads the Online Info they …

Expectant and new parents often turn to the internet for parenting prep, but it turns out that dads often don't seem to find the information they say they need about...

B.Braun Accelerator Call for Innovative …

B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. The company employs more than 60,000 employees in 64 countries and is looking for European...

Artificial Intelligence to Evaluate Brai…

Researchers at the University of Helsinki and the Helsinki University Hospital (HUH), Finland, have developed software based on machine learning, which can independently interpret EEG signals from a premature infant...

'NHS Cyber Security Batsignal' Peer-to-P…

The two chairs of the largest independent communities of NHS digital leaders will launch the 'NHS Cyber Security Batsignal', a new peer-to-peer cyber security warning alerting system, at the first...

New Highlights in the Programme for MEDI…

13 - 16 November 2017, Düsseldorf, Germany. The number of people in Germany who work in the health sector has increased to more than seven million for the first time during...